ACE and COVID-19: The results demonstrated that high doses of isochlorogenic acid C inhibited FXR/RXR, DPP4, JAK2, ACE, CNGA1, BLT1, COX-2, and 5-LOX, suggesting its potential to modulate COVID-19-related inflammatory pathways (Figure 5D).